AstraZeneca PLC (NYSE:AZN)

76.01
Data as of Aug 29
 +1.77 / +2.38%
Today’s Change
48.54
Today|||52-Week Range
82.68
+28.03%
Year-to-Date
Why AstraZeneca (AZN) Stock Is Higher Today
Aug 29 / TheStreet.com
Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
Aug 21 / Zacks.com
3 Health Care Stocks Pushing The Sector Higher
Aug 28 / TheStreet.com
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS - Analyst Blog
Aug 21 / Zacks.com
Should you buy ISIS? No, not that one
Aug 27 / CNNMoney.com
Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease - Analyst Blog
Aug 20 / Zacks.com
Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog
Aug 26 / Zacks.com
Ampio's Ampion Positive in Open Label Study, Shares Up - Analyst Blog
Aug 20 / Zacks.com
Burger King buying Tim Hortons
Aug 26 / CNNMoney.com
Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
Aug 20 / Zacks.com
The 4 Companies Teaming Up For A New Tool To Fight Cancer
Aug 25 / Benzinga
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
Aug 19 / Zacks.com
Roche to Boost Respiratory Product Lineup with InterMune Buy - Analyst Blog
Aug 25 / Zacks.com
Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
Aug 19 / Zacks.com
Roche Investors Should Breathe Easier After InterMune Acquisition
Aug 25 / TheStreet.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 / Zacks.com
AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog
Aug 22 / Zacks.com
Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod - Analyst Blog
Aug 19 / Zacks.com
Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
Aug 22 / Zacks.com
AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
Aug 18 / Zacks.com
Ampio Shares Fall as STEP Study on Ampion Gets Delayed - Analyst Blog
Aug 22 / Zacks.com
Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog
Aug 18 / Zacks.com
3 Reasons Bristol-Myers Squibb's Stock Could Rise
Aug 22 / MotleyFool.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
Aug 18 / Zacks.com
GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog
Aug 21 / Zacks.com
How to stay safe in a scary market
Aug 07 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.